Acorah Software Products - Accounts Production 16.3.350 false true true 31 December 2023 1 May 2023 false 29 May 2025 1 January 2024 31 December 2024 31 December 2024 10120536 Ms Minna Palhamo Mr Jussi Korpela BCBM Holding Oy true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10120536 2023-12-31 10120536 2024-12-31 10120536 2024-01-01 2024-12-31 10120536 frs-core:CurrentFinancialInstruments 2024-12-31 10120536 frs-core:OtherReservesSubtotal 2024-12-31 10120536 frs-core:ShareCapital 2024-12-31 10120536 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 10120536 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10120536 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 10120536 frs-bus:SmallEntities 2024-01-01 2024-12-31 10120536 frs-bus:Audited 2024-01-01 2024-12-31 10120536 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 10120536 1 2024-01-01 2024-12-31 10120536 frs-bus:Director1 2024-01-01 2024-12-31 10120536 frs-bus:CompanySecretary1 2024-01-01 2024-12-31 10120536 frs-countries:EnglandWales 2024-01-01 2024-12-31 10120536 2023-04-30 10120536 2023-12-31 10120536 2023-05-01 2023-12-31 10120536 frs-core:CurrentFinancialInstruments 2023-12-31 10120536 frs-core:OtherReservesSubtotal 2023-12-31 10120536 frs-core:ShareCapital 2023-12-31 10120536 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 10120536
BCB Medical Ltd
Financial Statements
For The Year Ended 31 December 2024
Accountum Limited
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 10120536
31 December 2024 31 December 2023
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 8,575 4,180
Cash at bank and in hand 92,149 -
100,724 4,180
Creditors: Amounts Falling Due Within One Year 5 (39,232 ) (47,689 )
NET CURRENT ASSETS (LIABILITIES) 61,492 (43,509 )
TOTAL ASSETS LESS CURRENT LIABILITIES 61,492 (43,509 )
NET ASSETS/(LIABILITIES) 61,492 (43,509 )
CAPITAL AND RESERVES
Called up share capital 6 1 1
Other reserves 445,300 -
Profit and Loss Account (383,809 ) (43,510 )
SHAREHOLDERS' FUNDS 61,492 (43,509)
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Minna Palhamo
Director
29/05/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
BCB Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10120536 . The registered office is Sweden House, 5 Upper Montagu Street, London, W1H 2AG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern. The parent company will continue to financially support the company for at least the 12 months following the approval of these financial statements.
2.3. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
2.5. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.6. Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.7. Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
3. Average Number of Employees
Average number of employees, excluding directors, during the year was: 2 (2023: 1)
2 1
Page 2
Page 3
4. Debtors
31 December 2024 31 December 2023
£ £
Due within one year
Other debtors 8,575 4,180
5. Creditors: Amounts Falling Due Within One Year
31 December 2024 31 December 2023
£ £
Amounts owed to group undertakings 1,590 33,461
Other creditors 17,574 8,555
Taxation and social security 20,068 5,673
39,232 47,689
The amounts due to group companies are repayable on demand, unsecured, and carry no interest.
Included in other creditors is £5,000 of accrued costs for audit fees (net of VAT - 2023: £4,284 gross of VAT).
6. Share Capital
31 December 2024 31 December 2023
£ £
Allotted, Called up and fully paid 1 1
Other reserves
Other reserves represents capital contributed by the parent undertaking in respect of which no shares have been issued to the parent company.
7. Related Party Transactions
The company is a wholly owned subsidiary member of it's group and has therefore taken advantage of the provisions of Section 33.1A of FRS102 not to disclose transactions with entities that are wholly owned members of the group.
Other than disclosed in these accounts, there were no other transactions with related parties that were not made under normal market conditions.
8. Ultimate Controlling Party
The company's immediate and ultimate controlling party is BCBM Holding Oy by virtue of their ownership of 100% of the issued share capital in the company.
9. Audit Information
The auditor's report on the accounts of BCB Medical Ltd for the year ended 31 December 2024 was unqualified.
The auditor's report was signed by William Watson (Senior Statutory Auditor) for and on behalf of Rawlinson & Hunter Audit LLP , Statutory Auditor.
Rawlinson & Hunter Audit LLP
Statutory Auditor & Chartered Accountants
Eighth Floor, 6 New Street Square, New Fetter Lane
London
EC4A 3AQ
Page 3